Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer

Por Hart, Christopher D, De Boer, Richard H
Publicado em 2013

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

Por Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Publicado no BMC Med (2015)

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with...

Por Malorni, Luca, Piazza, Silvano, Ciani, Yari, Guarducci, Cristina, Bonechi, Martina, Biagioni, Chiara, Hart, Christopher D., Verardo, Roberto, Leo, Angelo Di, Migliaccio, Ilenia
Publicado no Oncotarget (2016)